Matt D Stevenson

Summary

Affiliation: University of Sheffield
Country: UK

Publications

  1. ncbi request reprint Estimating the potential health gain and cost consequences of introducing a pre-school DTPa pertussis booster into the UK child vaccination schedule
    Matt Stevenson
    School of Health and Related Research, University of Sheffield, 30 Regent Street, Sheffield, South Yorkshire S1 4DA, UK
    Vaccine 20:1778-86. 2002
  2. ncbi request reprint Monte Carlo probabilistic sensitivity analysis for patient level simulation models: efficient estimation of mean and variance using ANOVA
    Anthony O'Hagan
    Department of Probability and Statistics, University of Sheffield, Sheffield S3 7RH, UK
    Health Econ 16:1009-23. 2007
  3. doi request reprint The cost-effectiveness of group cognitive behavioral therapy compared with routine primary care for women with postnatal depression in the UK
    Matt D Stevenson
    School of Health and Related Research, University of Sheffield, Sheffield, UK
    Value Health 13:580-4. 2010
  4. doi request reprint The cost effectiveness of a randomized controlled trial to establish the relative efficacy of vitamin K1 compared with alendronate
    Matt D Stevenson
    Centre for Bayesian Statistics in Health Economics, Health Economics and Decision Science, School of Health and Related Research, University of Sheffield, Sheffield, UK
    Med Decis Making 31:43-52. 2011
  5. doi request reprint Rivaroxaban for the prevention of venous thromboembolism: a single technology appraisal
    M Stevenson
    School of Health and Related Research, University of Sheffield, UK
    Health Technol Assess 13:43-8. 2009
  6. doi request reprint Febuxostat for the treatment of hyperuricaemia in people with gout: a single technology appraisal
    M Stevenson
    School of Health and Related Research, University of Sheffield, UK
    Health Technol Assess 13:37-42. 2009
  7. doi request reprint The cost-effectiveness of bosentan in the United Kingdom for patients with pulmonary arterial hypertension of WHO functional class III
    Matt D Stevenson
    School of Health and Related Research, University of Sheffield, 30 Regent Street, Sheffield, UK
    Value Health 12:1100-5. 2009
  8. doi request reprint The cost-effectiveness of an RCT to establish whether 5 or 10 years of bisphosphonate treatment is the better duration for women with a prior fracture
    Matt D Stevenson
    Operational Research, School of Health and Related Research, University of Sheffield, 30 Regent Street, Sheffield, S1 4DA, England, UK
    Med Decis Making 29:678-89. 2009
  9. doi request reprint Febuxostat for the management of hyperuricaemia in patients with gout: a NICE single technology appraisal
    Matt Stevenson
    School of Health and Related Research, University of Sheffield, Regent Court, 30 Regent Street, Sheffield, South Yorkshire, UK
    Pharmacoeconomics 29:133-40. 2011
  10. doi request reprint The population of health economic models is critical
    Matt Stevenson
    Bone 43:214; author reply 215-6. 2008

Collaborators

Detail Information

Publications11

  1. ncbi request reprint Estimating the potential health gain and cost consequences of introducing a pre-school DTPa pertussis booster into the UK child vaccination schedule
    Matt Stevenson
    School of Health and Related Research, University of Sheffield, 30 Regent Street, Sheffield, South Yorkshire S1 4DA, UK
    Vaccine 20:1778-86. 2002
    ..The introduction of a pre-school booster is predicted to reduce the number of hospitalisations by approximately 1400 and pertussis cases suffered by up to 28,000 at a net investment of under 13 million pounds over a 5-year period...
  2. ncbi request reprint Monte Carlo probabilistic sensitivity analysis for patient level simulation models: efficient estimation of mean and variance using ANOVA
    Anthony O'Hagan
    Department of Probability and Statistics, University of Sheffield, Sheffield S3 7RH, UK
    Health Econ 16:1009-23. 2007
    ..Methods are presented to estimate the mean and variance of the model output, with formulae for determining optimal sample sizes. The methods are simple to apply and will typically reduce the computational demand very substantially...
  3. doi request reprint The cost-effectiveness of group cognitive behavioral therapy compared with routine primary care for women with postnatal depression in the UK
    Matt D Stevenson
    School of Health and Related Research, University of Sheffield, Sheffield, UK
    Value Health 13:580-4. 2010
    ..To assess the cost-effectiveness of group cognitive behavior therapy (gCBT) in comparison with routine primary care for women with postnatal depression in the UK...
  4. doi request reprint The cost effectiveness of a randomized controlled trial to establish the relative efficacy of vitamin K1 compared with alendronate
    Matt D Stevenson
    Centre for Bayesian Statistics in Health Economics, Health Economics and Decision Science, School of Health and Related Research, University of Sheffield, Sheffield, UK
    Med Decis Making 31:43-52. 2011
    ..Furthermore, expected value of sample information (EVSI) analyses were undertaken to estimate whether a head-to-head trial of alendronate and vitamin K(1) would be considered cost effective...
  5. doi request reprint Rivaroxaban for the prevention of venous thromboembolism: a single technology appraisal
    M Stevenson
    School of Health and Related Research, University of Sheffield, UK
    Health Technol Assess 13:43-8. 2009
    ..The NICE guidance issued as a result of the STA states that: riveroxaban, within its marketing authorisation, is recommended as an option for the prevention of venous thromboembolism in adults having elective THR or elective TKB...
  6. doi request reprint Febuxostat for the treatment of hyperuricaemia in people with gout: a single technology appraisal
    M Stevenson
    School of Health and Related Research, University of Sheffield, UK
    Health Technol Assess 13:37-42. 2009
    ....
  7. doi request reprint The cost-effectiveness of bosentan in the United Kingdom for patients with pulmonary arterial hypertension of WHO functional class III
    Matt D Stevenson
    School of Health and Related Research, University of Sheffield, 30 Regent Street, Sheffield, UK
    Value Health 12:1100-5. 2009
    ....
  8. doi request reprint The cost-effectiveness of an RCT to establish whether 5 or 10 years of bisphosphonate treatment is the better duration for women with a prior fracture
    Matt D Stevenson
    Operational Research, School of Health and Related Research, University of Sheffield, 30 Regent Street, Sheffield, S1 4DA, England, UK
    Med Decis Making 29:678-89. 2009
    ....
  9. doi request reprint Febuxostat for the management of hyperuricaemia in patients with gout: a NICE single technology appraisal
    Matt Stevenson
    School of Health and Related Research, University of Sheffield, Regent Court, 30 Regent Street, Sheffield, South Yorkshire, UK
    Pharmacoeconomics 29:133-40. 2011
    ..The NICE Appraisal Committee concluded that febuxostat be recommended as an option for the management of chronic hyperuricaemia in gout only for people who are intolerant to allopurinol or for whom allopurinol is contraindicated...
  10. doi request reprint The population of health economic models is critical
    Matt Stevenson
    Bone 43:214; author reply 215-6. 2008
  11. ncbi request reprint The cost-effectiveness of risedronate treatment in Japanese women with osteoporosis
    Hansheng Ding
    Department of Health Administration and Policy, Graduate School of Medicine, Tohoku University, 2 1 Seiryo machi, Aoba ku, Sendai 980 8575, Japan
    J Bone Miner Metab 26:34-41. 2008
    ..However, providing BMD scans for women without a vertebral fracture in the previous 2 years was not cost-effective, even in women aged 85 years and older...